Dr. Gilles Amsallem, Chief Executive Officer
Gilles is a highly successful serial biotech entrepreneur. He has more than twenty years of experience in numerous areas of biotechnology, with a broad experience base, including scientific, industrial, financial and IPO expertise with companies including DIFCO, Litton Bionetics, DuPont, Sorin Biomedica, Biocon, and Avesthagen. Gilles was also the founder and CEO of Mixis Genetics, a London based Biotechnology company later acquired by Pfizer. Furthermore, Gilles has extensive experience creating strategic partnerships with large industrial companies, including Biomerieux, Danone and Limagrain. Gilles has a PhD in Molecular Biology and MD from Paris University. His work covered DNA repair and cancer with the esteemed Professor Matthew S. Meselson at Harvard University and with the lab of Molecular and Evolutionary Genetics at the Institute Jacques Monod in Paris. Gilles also has a Masters in International Business Law from IFRI Paris (French Institute of International Relations) and from Nice Sofia Antipolis University in France.